Regulatory Resources
Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools
21 CFR Part 812 — Investigational Device Exemption (IDE)
Allows investigational devices to be used in clinical studies to collect safety and effectiveness data in support of a PMA or 510(k) submission.
Download PDF21 CFR Part 814 — Premarket Approval (PMA)
Governs the most stringent FDA device pathway, required for Class III high-risk devices. Requires valid scientific evidence of safety and effectiveness, including clinical data.
Download PDF21 CFR Part 807 Subpart E — Premarket Notification 510(k)
Requires a 510(k) submission before commercial distribution of a device, demonstrating substantial equivalence to a legally marketed predicate device.
Download PDF21 CFR Part 807 — Establishment Registration and Device Listing
Requires domestic and foreign manufacturers to register with FDA and list their devices annually. Foreign manufacturers must designate a US Agent.
Download PDFFD&C Act — Federal Food, Drug, and Cosmetic Act
The foundational US law authorizing FDA to regulate medical devices. Sections 513–520 govern device classification, premarket review, postmarket requirements, and enforcement.
Download PDFEU AI Act — Regulation (EU) 2024/1689 — Official Full Text
The EU AI Act (Regulation 2024/1689) establishes a harmonised legal framework for artificial intelligence in the EU, with key implications for AI-enabled medical devices under MDR and IVDR.
Download PDFSingapore meeting outcome statement
Outcome statement published by IMDRF.
Download PDFSydney meeting outcome statement
Outcome statement published by IMDRF.
Download PDFFrance meeting outcome statement
Outcome statement published by IMDRF.
Download PDFSan Fransisco meeting outcome statement
Outcome statement published by IMDRF.
Download PDF